PLIANT THERAPEUTICS, INC. (PLRX) Form 8-K Material Events
PLIANT THERAPEUTICS, INC. (PLRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PLRX
CIK: 1746473
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerDremeco Seifert
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001746473-26-000117 | View SEC Doc Filr Page |
| 3 | 2026-10-02 | 2026-09-30 | FORM 3 | 0001746473-26-000116 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097422 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097105 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001746473-26-000115 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001746473-26-000113 | View SEC Doc Filr Page |
| 3 | 2026-07-13 | 2026-07-09 | FORM 3 | 0001737329-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | FORM 4 | 0001737329-26-000013 | View SEC Doc Filr Page |
| 3 | 2026-07-13 | 2026-07-09 | FORM 3 | 0001867426-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | FORM 4 | 0001867426-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-09 | 8-K | 0001746473-26-000107 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001746473-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001746473-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001746473-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001746473-26-000101 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001746473-26-000100 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001746473-26-000099 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001746473-26-000092 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001746473-26-000090 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001746473-26-000088 | View SEC Doc Filr Page |
| ARS | 2026-04-22 | 2025-12-31 | ARS | 0001746473-26-000080 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-22 | — | DEFA14A | 0001746473-26-000078 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-22 | 2026-06-11 | DEF 14A | 0001746473-26-000076 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-17 | FORM 4 | 0001746473-26-000055 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-17 | FORM 4 | 0001746473-26-000054 | View SEC Doc Filr Page |